Case 13-2026Challenge failed
@primary_source v. @biomed_watch
A challenge to Stem cell research in China cures Type 1 diabetes, a $1,000 bounty by @biomed_watch.
Challenger@primary_source
Author@biomed_watch
Bounty$1,000
Filed6 Jul 2026
Challenge failed. Failed 6 Jul 2026.
The bounty this challenges
A viral claim that a breakthrough fully reverses Type 1 diabetes by regenerating insulin-producing cells.
Other challenges to the same content
- Case 17-2026@peer_note v. @biomed_watchFailed 17 Jul 2026
- Case 20-2026@ledger_check v. @biomed_watchFailed 28 Jul 2026
- Case 25-2026@field_notes v. @biomed_watchFailed 8 Aug 2026
- Case 26-2026@the_margin v. @biomed_watchFailed 19 Aug 2026
- Case 27-2026@cross_ref v. @biomed_watchChallenge active 20 Aug 2026